Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

November 21, 2024
BioUtah News Policy News
BioUtah Award Winners and Utah Rare Disease Advisory Council Take Center Stage at Utah Life Sciences Innovation Caucus

More than a dozen Utah legislators on Wednesday, November 20, held a breakfast meeting of the Utah Life Sciences Innovation Caucus (ULSIC) at the state capitol.

November 21, 2024
BioUtah News
Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy

Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy

November 21, 2024
BioUtah News
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2

Agreement will expand worldwide access and better position Myriad’s GIS as a potential companion diagnostic across multiple potential tumor types

November 21, 2024
BioUtah News
EVŌQ Nano Expands Antimicrobial Medical Device Platform, Demonstrates Efficacy Across Multiple Device Applications

Four Integration Methods Aim to Combat Healthcare-Associated Infections & Improve Device Performance

November 21, 2024
BioUtah News
SINTX TECHNOLOGIES AND NED MEDICAL PARTNER TO ADVANCE CUTTING-EDGE CERAMIC MICROSPHERE MEDICAL DEVICES FOR CANCER TREATMENT

SINTX TECHNOLOGIES AND NED MEDICAL PARTNER TO ADVANCE CUTTING-EDGE CERAMIC MICROSPHERE MEDICAL DEVICES FOR CANCER TREATMENT

November 21, 2024
BioUtah News
First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities

First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities

November 14, 2024
BioUtah News
Recursion and Exscientia Shareholders Approve the Proposed Combination

Update call scheduled for November 20th at 7:30 a.m. Eastern with anticipated close

November 14, 2024
BioUtah News
Recursion Announces the Release of OpenPhenom-S/16 in Google Cloud’s Model Garden

OpenPhenom is a non-commercial, publicly available foundation model built on microscopy data that has set the new “gold standard” outperforming CellProfiler

November 14, 2024
BioUtah News
The Future Of Inflammation: The Inflammasome And Beyond

Novel targets for managing inflammation hold the promise of greater efficacy and safety for diseases not widely viewed as inflammatory in nature.

November 14, 2024
BioUtah News
Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch

SneakPeek®, the first at-home early fetal sex test for use at six weeks, is now available at over 8,800 retail locations nationwide.

November 14, 2024
BioUtah News
2024 ULSS Recap

BioUtah yesterday held its 2024 Utah Life Sciences Summit, sponsored by Mayer Brown. Every year, the Summit is the largest gathering of Utah’s life sciences industry. This year was no exception. A distinguished line-up of industry leaders and inspiring speakers addressed a packed house. Utah Governor Spencer Cox welcomed attendees to kick off the day-long […]

November 14, 2024
BioUtah News
Ross Southern Laboratories achieves certification to ISO 9001

Ross Southern Laboratories (RSL) proudly announces its ISO 9001 certification for its Quality Management System

October 24, 2024
BioUtah News
Cellino Appoints Chris Gibson to Board of Directors

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cellino Biotech, Inc., a biotechnology company advancing autonomous, closed biomanufacturing for personalized regenerative medicines, today announced the appointment of Chris Gibson to the company’s Board of Directors. “Cellino’s proprietary technology stack, including optical bioprocessing, closed cassettes, and image-guided co-pilots, has the potential to transform healthcare and bring potentially curative therapies to millions of […]

October 24, 2024
BioUtah News
Recursion and Google Cloud Announce Expansion of Partnership to Support Drug Discovery with Cloud and Exploration of Generative AI Technologies

SALT LAKE CITY and SUNNYVALE, Calif., Oct. 21, 2024 /PRNewswire/ — Recursion, a leading TechBio company decoding biology to radically improve lives, and Google Cloud today announced an expanded collaboration leveraging Google Cloud’s technologies to support Recursion’s drug discovery platform. This strategic partnership includes exploring generative AI capabilities, including Gemini models, to support the RecursionOS, […]

October 24, 2024
BioUtah News
U Announces Life-Saving Lab Pushing Limits of Medical Technology

The University of Utah, one of the nation’s leading research universities, has just announced the launch of a new laboratory called the Applied MedicalEngineering (AME) Lab. The AME Lab’s ambitious mission is to create cutting-edge medical technologies designed to deliver life-saving care to any patient with any injury at any location for any duration. The […]

October 24, 2024
BioUtah News
NUSANO AND STARGET PHARMA ANNOUNCE SUPPLY AGREEMENT TO ACCELERATE SMART TARGETED RADIOLIGAND DEVELOPMENT

VALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a physics company transforming the production of radioisotopes, and Starget Pharma, a clinical-stage biotechnology company developing precision peptide radioligand therapies focused on difficult to treat cancers, today announced a supply agreement to advance the development of Starget’s Smart Targeted Radioligands (STRs). The supply […]

October 17, 2024
BioUtah News
Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration

Myriad’s MyRisk® test is the first hereditary cancer test integrated into Flatiron’s OncoEMR® SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with Flatiron Health, a leading health tech company dedicated to expanding the possibilities of point of care […]

October 17, 2024
BioUtah News
Halia Therapeutics to Participate in Panel at BIO Investor Forum 2024

LEHI, Utah, Oct. 14, 2024 /PRNewswire/ — Halia Therapeutics, Inc. (Halia), a clinical-stage biopharmaceutical company at the forefront of developing innovative treatments for inflammatory and neurodegenerative diseases, today announced that David J. Bearss, Ph.D., President and CEO of Halia Therapeutics, will participate in a panel at the BIO Investor Forum taking place October 15-16, 2024, in […]

October 17, 2024
BioUtah News
Canary Speech Launches Canary Ambient™, a First-of-its-Kind, Real-Time Voice Analysis for Clinical Conversations

Canary Ambient™ enables actionable insights into patient-clinician dialogues, tracking speech patterns, and delivering real-time evaluations of cognitive and behavioral health conditions PROVO, Utah, Oct. 16, 2024 /PRNewswire/ — Canary Speech, a leader in vocal biomarker technology, has announced today the launch of Canary Ambient™, an API-first solution designed for healthcare and contact centers, which offers a […]

October 17, 2024
BioUtah News
Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access

SALT LAKE CITY, Oct. 16, 2024 (GLOBE NEWSWIRE) — Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a strategic partnership with jscreen™, a national organization that delivers education and access to preventative genetic testing with a focus on high-risk populations. The collaboration combines the strengths of Myriad’s high-quality […]

October 11, 2024
BioUtah News
Canyon Labs Expands Capabilities With Acquisition of Life Pack Labs

Utah-based Canyon Labs announces its strategic acquisition of Life Pack Labs in California, broadening its service offerings and enhancing its position as an industry leader in medical device and pharmaceutical compliance testing. SALT LAKE CITY, October 8, 2024 (Newswire.com) – Canyon Labs, a leading medical device & pharmaceutical consulting, sterility assurance, analytical chemistry and package […]

October 10, 2024
BioUtah News
Scientists at Utah State University Receive Grants to Study Two Important Viruses

Researchers at Utah State University, led by Professor Zhongde Wang and collaborating with teams at University of Texas Medical Branch and University of Pittsburgh, respectively, have secured two grants from the National Institutes of Health (NIH) totaling more than $4 million in recent months to advance the understanding of two important global health threats. In […]

October 10, 2024
BioUtah News
Life Sciences Delegation Participates in Governor’s Trade Mission to Korea and Japan

BioUtah and five BioUtah member companies participated in the Governor’s trade mission to Korea and Japan organized by World Trade Center Utah. Led by BioUtah president and CEO, Kelvyn Cullimore, the life sciences delegation included Dwight Egan, Seth Egan and Richard Abbott of CoDiagnostics, Mike Kirkness and Lucas Bennink of 3Helix, Taylor Avei of Halia […]